References
- Panay N, Fenton A. Menopause – natural selection or modern disease? Climacteric 2015;18:1–2
- Labrie F, Labrie C. DHEA and intracrinology at menopause, a positive choice for evolution of the human species. Climacteric 2013;16:205–13
- Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002;288:321–33
- Labrie F, Ke Y, Gonthier R, Bélanger A. Why both LC-MS/MS and FDA-compliant validation are essential for accurate estrogen assays? J Steroid Biochem Mol Biol 2015;149C:89–91
- Labrie F, Martel C, Balser J. Wide distribution of the serum dehydroepiandrosterone and sex steroid levels in postmenopausal women: role of the ovary? Menopause 2011;18:30–43
- Labrie F. All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause. JSBMB 2015;145:133–8
- Luu-The V, Labrie F. The intracrine sex steroid biosynthesis pathways. In Martini L, Chrousos GP, Labrie F, Pacak K, Pfaff De, eds. Neuroendocrinology, Pathological Situations and Diseases, Progress in Brain Research. New York: Elsevier, 2010: 177–92
- Belanger A, Pelletier G, Labrie F, Barbier O, Chouinard S. Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans. Trends Endocrinol Metab 2003; 14:473–9
- Labrie F, Archer DF, Bouchard C, et al. Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration. Menopause 2009;16:897–906
- Archer DF, Labrie F, Bouchard C, et al. Treatment of pain at sexual activity (dyspareunia) with intravaginal dehydroepaindrosterone (prasterone). Menopause 2015 Mar 2. Epub ahead of print
- Portman DJ, Labrie F, Archer DF, et al. Lack of effect of intravaginal dehydroepiandrosterone (DHEA, prasterone) on the endometrium in postmenopausal women. Menopause 2015 May 11. Epub ahead of print